Open Access
Current Practices for Multimodal Pain Management Using Liposomal Bupivacaine in Extracapsular and Intracapsular Hip Fracture Surgery: Expert Panel Opinion
Author(s) -
Nirav H. Amin,
Hank L Hutchinson,
Anthony G Sanzone
Publication year - 2018
Publication title -
journal of orthopaedic trauma
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.221
H-Index - 121
eISSN - 1531-2291
pISSN - 0890-5339
DOI - 10.1097/bot.0000000000001226
Subject(s) - medicine , bupivacaine , acetaminophen , hip fracture , multimodal therapy , tramadol , surgery , anesthesia , opioid , analgesic , osteoporosis , receptor , endocrinology
Liposomal bupivacaine (LB) has demonstrated efficacy across a range of surgical settings, including shoulder, knee, and hip surgery. However, data are limited on the use of LB as part of a multimodal pain management approach in hip fracture surgery.